| Medical Mutual | Lamzede® (velmanase alfa-tycv) (Intravenous) | 2026-04-01 |
| Medical Mutual | Lenmeldy™ (atidarsagene autotemcel) (Intravenous) | 2026-04-01 |
| Medical Mutual | Mylotarg™ (gemtuzumab ozogamicin) (Intravenous) | 2026-04-01 |
| Medical Mutual | Opdivo Qvantig™ (nivolumab and hyaluronidase-nvhy) (EOV) | 2026-04-01 |
| Medical Mutual | Opdivo® (nivolumab) (Intravenous) (EOV) | 2026-04-01 |
| Medical Mutual | Oncology Value: Pombiliti® (cipaglucosidase alfa-atga) (Intravenous) | 2026-04-01 |
| Medical Mutual | Poteligeo® (mogamulizumab-kpkc) (Intravenous) | 2026-04-01 |
| Medical Mutual | Rituxan Hycela® (rituximab and hyaluronidase human) (Subcutaneous) (EOV) | 2026-04-01 |
| Medical Mutual | Rituxan Hycela® (rituximab and hyaluronidase human) (Subcutaneous) | 2026-04-01 |
| Medical Mutual | Talvey® (talquetamab-tgvs) (Subcutaneous) (EOV) | 2026-04-01 |